DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
4.240
+0.220 (5.47%)
Nov 21, 2024, 1:18 PM EST - Market open
DiaMedica Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 4.13 | 4.54 | 4.73 | 4.71 | 7.41 | 3.88 | Upgrade
|
| Short-Term Investments | 46.06 | 48.35 | 28.77 | 40.41 | 20.1 | 4 | Upgrade
|
| Cash & Short-Term Investments | 50.2 | 52.9 | 33.5 | 45.11 | 27.51 | 7.88 | Upgrade
|
| Cash Growth | 8.03% | 57.89% | -25.74% | 64.00% | 249.16% | -53.17% | Upgrade
|
| Other Receivables | 0.29 | 0.37 | 0.08 | 0.13 | 0.34 | 0.82 | Upgrade
|
| Receivables | 0.29 | 0.37 | 0.08 | 0.13 | 0.34 | 0.82 | Upgrade
|
| Prepaid Expenses | 0.28 | 0.09 | 0.21 | 0.08 | 0.06 | 0.05 | Upgrade
|
| Other Current Assets | - | 0.32 | 0.04 | 0.11 | 0.01 | 0.09 | Upgrade
|
| Total Current Assets | 50.77 | 53.68 | 33.84 | 45.44 | 27.92 | 8.84 | Upgrade
|
| Property, Plant & Equipment | 0.45 | 0.49 | 0.56 | 0.11 | 0.17 | 0.22 | Upgrade
|
| Other Long-Term Assets | 1.31 | - | - | - | - | - | Upgrade
|
| Total Assets | 52.52 | 54.16 | 34.4 | 45.55 | 28.1 | 9.05 | Upgrade
|
| Accounts Payable | 1.17 | 0.93 | 0.73 | 0.51 | 1.1 | 0.18 | Upgrade
|
| Accrued Expenses | 3.02 | 1.78 | 1.37 | 0.97 | 0.86 | 1.02 | Upgrade
|
| Current Portion of Leases | 0.1 | 0.08 | 0.07 | 0.05 | 0.07 | 0.06 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | - | 0.05 | Upgrade
|
| Total Current Liabilities | 4.3 | 2.79 | 2.17 | 1.52 | 2.03 | 1.32 | Upgrade
|
| Long-Term Leases | 0.26 | 0.32 | 0.4 | 0 | 0.05 | 0.12 | Upgrade
|
| Total Liabilities | 4.56 | 3.1 | 2.57 | 1.53 | 2.08 | 1.44 | Upgrade
|
| Additional Paid-In Capital | 179.99 | 166.61 | 128.08 | 126.58 | 94.93 | 64.23 | Upgrade
|
| Retained Earnings | -132.1 | -115.56 | -96.18 | -82.5 | -68.91 | -56.62 | Upgrade
|
| Comprehensive Income & Other | 0.08 | 0.01 | -0.07 | -0.05 | -0 | 0 | Upgrade
|
| Shareholders' Equity | 47.96 | 51.06 | 31.83 | 44.02 | 26.01 | 7.62 | Upgrade
|
| Total Liabilities & Equity | 52.52 | 54.16 | 34.4 | 45.55 | 28.1 | 9.05 | Upgrade
|
| Total Debt | 0.37 | 0.4 | 0.47 | 0.05 | 0.12 | 0.18 | Upgrade
|
| Net Cash (Debt) | 49.83 | 52.5 | 33.03 | 45.06 | 27.39 | 7.7 | Upgrade
|
| Net Cash Growth | -10.68% | 58.92% | -26.69% | 64.52% | 255.70% | -54.17% | Upgrade
|
| Net Cash Per Share | 1.27 | 1.61 | 1.25 | 2.17 | 1.75 | 0.64 | Upgrade
|
| Filing Date Shares Outstanding | 42.76 | 37.96 | 26.46 | 26.44 | 18.78 | 14.14 | Upgrade
|
| Total Common Shares Outstanding | 42.77 | 37.96 | 26.44 | 26.44 | 18.75 | 12.01 | Upgrade
|
| Working Capital | 46.47 | 50.89 | 31.67 | 43.92 | 25.89 | 7.52 | Upgrade
|
| Book Value Per Share | 1.12 | 1.35 | 1.20 | 1.66 | 1.39 | 0.63 | Upgrade
|
| Tangible Book Value | 47.96 | 51.06 | 31.83 | 44.02 | 26.01 | 7.62 | Upgrade
|
| Tangible Book Value Per Share | 1.12 | 1.35 | 1.20 | 1.66 | 1.39 | 0.63 | Upgrade
|
| Machinery | - | 0.22 | 0.2 | 0.14 | 0.13 | 0.11 | Upgrade
|
| Leasehold Improvements | - | 0.02 | 0.02 | 0 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.